A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMC 4120868)

Published in Blood on May 15, 1993

Authors

D C Dale1, M A Bonilla, M W Davis, A M Nakanishi, W P Hammond, J Kurtzberg, W Wang, A Jakubowski, E Winton, P Lalezari

Author Affiliations

1: Department of Medicine, University of Washington, Seattle 98195.

Articles citing this

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood (2007) 3.73

Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood (2006) 2.82

Hematopoietic cytokines. Blood (2008) 2.45

Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine (2008) 1.95

Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? Cytotherapy (2009) 1.73

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood (2014) 1.66

Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis (2011) 1.66

Biosimilar agents in oncology/haematology: from approval to practice. Eur J Haematol (2011) 1.64

SerpinB1 protects the mature neutrophil reserve in the bone marrow. J Leukoc Biol (2011) 1.60

The colony-stimulating factors and cancer. Nat Rev Cancer (2010) 1.44

Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest (2008) 1.41

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol (2007) 1.37

Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest (1998) 1.20

Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol (2010) 1.17

A truncation mutant of Csf3r cooperates with PML-RARα to induce acute myeloid leukemia in mice. Exp Hematol (2011) 1.17

Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia. Haematologica (2013) 1.11

Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun (2007) 1.03

JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia. Nat Genet (2014) 1.01

G-CSF and GM-CSF in Neutropenia. J Immunol (2015) 0.98

The investigation and management of chronic neutropenia in children. Arch Dis Child (2006) 0.97

The inherited bone marrow failure syndromes. Pediatr Clin North Am (2013) 0.97

Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med (1999) 0.95

Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil? Curr Opin Allergy Clin Immunol (2007) 0.94

Evaluation and management of patients with isolated neutropenia. Semin Hematol (2013) 0.93

Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice. Eur J Cancer Care (Engl) (2013) 0.90

Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia. J Clin Immunol (2011) 0.89

Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol (2009) 0.89

Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 0.88

Inherited bone marrow failure syndromes in adolescents and young adults. Ann Med (2014) 0.88

Severe congenital neutropenia: genetics and pathogenesis. Trans Am Clin Climatol Assoc (2006) 0.87

Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia. J Korean Med Sci (2011) 0.86

Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole. Antimicrob Agents Chemother (1997) 0.86

Haemopoietic colony stimulating factors for preterm neonates. Arch Dis Child Fetal Neonatal Ed (1997) 0.85

Inherited biallelic CSF3R mutations in severe congenital neutropenia. Blood (2014) 0.84

Progenitor cell self-renewal and cyclic neutropenia. Cell Prolif (2009) 0.84

Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS. Pediatr Rep (2011) 0.82

Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy. Front Oncol (2014) 0.82

Paradoxical drop in circulating neutrophil count following granulocyte-colony stimulating factor and stem cell factor administration in rhesus macaques. Exp Hematol (2007) 0.81

Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R. Haematologica (2013) 0.80

Old and new faces of neutropenia in children. Haematologica (2016) 0.79

Neutropenia in primary immunodeficiency. Curr Opin Hematol (2013) 0.79

Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10, and GM-CSF. Indian J Hematol Blood Transfus (2011) 0.79

Radioprotective effects of Sipunculus nudus L. polysaccharide combined with WR-2721, rhIL-11 and rhG-CSF on radiation-injured mice. J Radiat Res (2015) 0.79

How I diagnose and treat neutropenia. Curr Opin Hematol (2016) 0.79

Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med (2012) 0.79

The effect of recombinant granulocyte colony-stimulating factor on oral and periodontal manifestations in a patient with cyclic neutropenia: a case report. Int J Dent (2010) 0.78

Understanding, treating and avoiding hematological disease: better medicine through mathematics? Bull Math Biol (2014) 0.77

High frequency spikes in long period blood cell oscillations. J Math Biol (2006) 0.77

Neutrophil biology and the next generation of myeloid growth factors. J Natl Compr Canc Netw (2009) 0.77

The discovery, development and clinical applications of granulocyte colony-stimulating factor. Trans Am Clin Climatol Assoc (1998) 0.77

Animal models of human granulocyte diseases. Hematol Oncol Clin North Am (2012) 0.76

Advances in haematological pharmacotherapy in 21st century. Indian J Hematol Blood Transfus (2010) 0.75

Severe congenital neutropenia due to G6PC3 deficiency: early and delayed phenotype in two patients with two novel mutations. Ital J Pediatr (2014) 0.75

Cataract associated with high-dose hematopoietic colony stimulating factor, case report and literature review. Saudi Pharm J (2010) 0.75

The use of haemopoietic growth factors in blood disorders. Arch Dis Child (1994) 0.75

Aerobic exercise in humans mobilizes HSC in an intensity dependent manner. J Appl Physiol (1985) (2016) 0.75

An update on the diagnosis and treatment of chronic idiopathic neutropenia. Curr Opin Hematol (2017) 0.75

Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol (2017) 0.75

Response of an oscillatory differential delay equation to a single stimulus. J Math Biol (2016) 0.75

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer (2017) 0.75

Articles cited by this

THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr (1964) 4.12

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science (1986) 3.92

Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 3.02

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.31

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med (1989) 1.67

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67

Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl (1956) 1.59

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55

"MYELOKATHEXIS"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE. N Engl J Med (1964) 1.44

Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med (1989) 1.42

Studies on cyclic neutropenia; a clinical and experimental investigation. AMA J Dis Child (1957) 1.37

Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology (1986) 1.26

T gamma-lymphoproliferative disease and related disorders in humans and experimental animals: a review of the clinical, cellular, and functional characteristics. Blood (1984) 1.23

CHRONIC IDIOPATHIC GRANULOCYTOPENIA. N Engl J Med (1964) 1.18

Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med (1989) 1.12

Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood (1990) 1.12

Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) (1981) 1.10

Cyclic neutropenia: a clinical review. Blood Rev (1988) 1.08

Chronic hypoplastic neutropenia. Am J Med (1952) 0.99

Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis. J Pediatr (1991) 0.98

TREATMENT OF CYCLIC NEUTROPENIA WITH TESTOSTERONE. Am J Med (1965) 0.95

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. Cancer Res (1991) 0.95

Chronic neutropenia. Medicine (Baltimore) (1979) 0.93

Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr Scand (1975) 0.93

Cyclic neutropenia and T lymphocyte suppression of granulopoiesis: abrogation of the neutropenic cycles by lithium carbonate. Leuk Res (1982) 0.91

Correction of human cyclic neutropenia with prednisolone. N Engl J Med (1978) 0.89

Effect of oxymetholone on human cyclic haematopoiesis. Br J Haematol (1981) 0.87

Cyclic neutropenia: amplification of granulocyte oscillations by lithium and long-term suppression of cycling by plasmapheresis. Blood (1983) 0.87

Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol (1992) 0.85

Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med (1980) 0.85

In vitro functions of neutrophils induced by treatment with rhG-CSF in severe congenital neutropenia. Eur J Haematol (1991) 0.84

Lithium therapy in childhood neutropenia. J Pediatr (1983) 0.84

Treatment of idiopathic chronic neutropenia with high-dose intravenous immunoglobulin. Am J Dis Child (1987) 0.83

Measurement of serum granulocyte colony-stimulating factor in a patient with congenital agranulocytosis (Kostmann's syndrome). Am J Dis Child (1991) 0.83

Childhood neutropenia. Pediatr Clin North Am (1980) 0.82

Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood (1986) 0.82

The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum (1992) 0.81

rhG-CSF for Shwachman's syndrome. Lancet (1990) 0.80

Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor. Br J Haematol (1990) 0.80

Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet (1990) 0.80

rhG-CSF and aztreonam as prophylaxis against infection in neutropenic children. Lancet (1991) 0.80

Treatment of childhood-onset cyclic neutropenia with recombinant human granulocyte colony-stimulating factor. Eur J Haematol (1990) 0.79

Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor. Ann Hematol (1991) 0.79

Disappearance of neutrophil oscillations in a child with cyclic neutropenia after treatment with recombinant human granulocyte colony-stimulating factor. Eur J Haematol (1990) 0.79

Articles by these authors

Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78

A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87

NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51

Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07

Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 6.15

Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13

Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (1994) 5.47

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41

Rapid evolution of male reproductive genes in the descent of man. Nature (2000) 5.33

Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development (1995) 5.18

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14

Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell (1998) 4.95

A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med (1969) 4.70

Bone development. Annu Rev Cell Dev Biol (2000) 4.24

Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med (1991) 3.52

Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45

The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci U S A (2000) 3.16

BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell (2000) 2.94

Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature (2005) 2.74

Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science (1999) 2.71

Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71

A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68

The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67

Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol (1994) 2.59

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol (1996) 2.59

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood (1999) 2.59

Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci U S A (1993) 2.57

Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation (2001) 2.56

Mobilization of a Drosophila transposon in the Caenorhabditis elegans germ line. Nature (2001) 2.55

avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J (1997) 2.55

Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc (2001) 2.55

Hormonal changes in the grains of rice subjected to water stress during grain filling. Plant Physiol (2001) 2.52

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52

Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther (2001) 2.51

Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46

Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A (1989) 2.45

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43

Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst (2001) 2.41

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med (1988) 2.40

Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood (1990) 2.38

Pattern of marine mass extinction near the Permian-Triassic boundary in South China. Science (2000) 2.38

De novo amyloid proteins from designed combinatorial libraries. Proc Natl Acad Sci U S A (1999) 2.38

Predicting caries in permanent teeth from caries in primary teeth: an eight-year cohort study. J Dent Res (2002) 2.35

ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest (1998) 2.29

A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proc Natl Acad Sci U S A (2000) 2.24

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24

Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol (2000) 2.22

Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22

TRAPP I implicated in the specificity of tethering in ER-to-Golgi transport. Mol Cell (2001) 2.20

Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17

Quality of life for children with fecal incontinence after surgically corrected anorectal malformation. J Pediatr Surg (2000) 2.17

Mortality and cardiovascular disease among older live kidney donors. Am J Transplant (2014) 2.16

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene (2000) 2.15

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11

Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (2001) 2.10

Validity of the ten questions screened for childhood disability: results from population-based studies in Bangladesh, Jamaica, and Pakistan. Epidemiology (1994) 2.10

Hydration of fat-free body mass: new physiological modeling approach. Am J Physiol (1999) 2.09

Ethical aspects of banking placental blood for transplantation. JAMA (1995) 2.07

Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol (2015) 2.07

Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry (2000) 2.03

Successful therapy for trilateral retinoblastoma. Am J Ophthalmol (1992) 2.03

Repeatability of the Pedar-X in-shoe pressure measuring system. Foot Ankle Surg (2009) 2.03

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol (2001) 2.02

Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01

A frame shift mutation in the DNA-binding domain of the androgen receptor gene associated with complete androgen insensitivity, persistent müllerian structures, and germ cell tumors in dysgenetic gonads. Fertil Steril (1999) 2.00

Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics (1996) 1.98

The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes (2004) 1.96

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95

Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood (1998) 1.95

The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94

HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene (2006) 1.94

Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol Cell Biol (2000) 1.93

Intraocular lens power calculation after laser in situ keratomileusis for myopia and hyperopia: a standardized approach. Cornea (2001) 1.90

H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol (1992) 1.89

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia (1999) 1.89

Curbing the nonsense: the activation and regulation of mRNA surveillance. Genes Dev (2001) 1.87

Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol (1985) (2009) 1.86

Harvesting energy from the marine sediment--water interface. Environ Sci Technol (2001) 1.85

Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol (2014) 1.85

Chemical constituents from Dendrobium densiflorum. Phytochemistry (2001) 1.82

A computational approach to simplifying the protein folding alphabet. Nat Struct Biol (1999) 1.82

Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82

Trp1, a candidate protein for the store-operated Ca(2+) influx mechanism in salivary gland cells. J Biol Chem (2000) 1.82

The EH and SH3 domain Ese proteins regulate endocytosis by linking to dynamin and Eps15. EMBO J (1999) 1.82

A mew method for detection of red blood cell antibodies. Transfusion (1970) 1.81

Evaluating a ten questions screen for childhood disability: reliability and internal structure in different cultures. J Clin Epidemiol (1995) 1.79

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78

Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol (1985) (1999) 1.78

Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77

Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76

Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry (2011) 1.76

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood (1992) 1.76